O-p′DDD therapy in Cushing's syndrome and in obesity with Cushingoid changes
- 31 August 1964
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 37 (2) , 235-250
- https://doi.org/10.1016/0002-9343(64)90008-7
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- IODOTYROSYL COUPLING DEFECT IN CONGENITAL HYPOTHYROIDISM WITH GOITREThe Lancet, 1963
- Therapy of Adrenocortical Cancer with o,p′ DDD in Two ChildrenJournal of Clinical Endocrinology & Metabolism, 1963
- Cushing's Syndrome Due to Adrenocortical HyperplasiaNew England Journal of Medicine, 1961
- A TEST OF PITUITARY RESERVE UTILIZING INTRAVENOUS SU-4885, WITH A NEW METHOD FOR EXTRACTION OF 11-DESOXYCORTICOSTEROIDSJournal of Clinical Endocrinology & Metabolism, 1960
- THYROIDITIS FOLLOWING ADMINISTRATION OF THYROID-STIMULATING HORMONE*Journal of Clinical Endocrinology & Metabolism, 1960
- CHEMOTHERAPY OF ADRENOCORTICAL CANCER WITH o,p′DDDAnnals of Internal Medicine, 1960
- HYPOKALÆMIA, CARCINOMA AND CUSHING'S SYNDROMEThe Lancet, 1960
- POTENTIATION AND STABILIZATION OF AORTIC STRIP PRESSOR ASSAY BY PLASMA AND HYDROCORTISONEThe Lancet Healthy Longevity, 1960
- Regression of Adrenal Cancer and Suppression of Adrenal Function in Man by o,p′-DDDPublished by Elsevier ,1960
- STUDIES OF ADRENOCORTICAL FUNCTION IN OBESITYJournal of Clinical Endocrinology & Metabolism, 1959